Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2016-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2016-1005PMID 27144933PMCID PMC7958923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum

  2016cited by this paper
• Berardinelli-Seip syndrome and achalasia: a shared pathomechanism?

  2015cited by this paper
• Congenital generalized lipodystrophies—new insights into metabolic dysfunction

  2015cited by this paper
• MutationTaster2: mutation prediction for the deep-sequencing age

  2014influential reference
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• Metreleptin: First Global Approval

  2013cited by this paper
• Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.

  2013cited by this paper
• Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1

  2012cited by this paper
• Lipodystrophies: Genetic and Acquired Body Fat Disorders

  2011cited by this paper
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

  2011cited by this paper
• Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency

  2010cited by this paper
• Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations

  2010influential reference
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Fatal Cardiac Arrhythmia and Long-QT Syndrome in a New Form of Congenital Generalized Lipodystrophy with Muscle Rippling (CGL4) Due to PTRF-CAVIN Mutations

  2010cited by this paper
• Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.

  2010cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli–Seip congenital generalized lipodystrophy syndrome

  2009cited by this paper
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009influential reference
• Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.

  2009cited by this paper
• Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis.

  2009cited by this paper
• Caveolin-1: a new locus for human lipodystrophy.

  2008influential reference
• Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.

  2008cited by this paper
• Genetic disorders of adipose tissue development, differentiation, and death.

  2006cited by this paper
• Successful Renal Transplantation in a Patient with Congenital Generalized Lipodystrophy: A Case Report

  2004cited by this paper
• Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.

  2004cited by this paper
• Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation.

  2004cited by this paper
• Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.

  2003cited by this paper
• Prevalence of mutations in AGPAT2 among human lipodystrophies.

  2003cited by this paper
• Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.

  2003cited by this paper
• Leptin-replacement therapy for lipodystrophy.

  2002cited by this paper
• Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy

  2002cited by this paper
• AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13

  2001cited by this paper
• Lipodystrophies.

  2000cited by this paper
• Congenital generalized lipodystrophy: Berardinelli syndrome. Report of two siblings.

  1995cited by this paper
• National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

  1992cited by this paper
• Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

  1992cited by this paper
• RENAL TRANSPLANTATION IN A PATIENT WITH LIPOATROPHIC DIABETES A CASE REPORT

  1978cited by this paper

• Berardinelli–Seip congenital lipodystrophy type-2: a case series of three Indian children

  2026cites this paper
• A Multisystem Perspective of Pediatric Cell Trafficking Disorders: Within the Cells, Beneath the Signs

  2025cites this paper
• Diagnosis of Congenital and Acquired Generalized Lipodystrophies—Similarities and Differences

  2025cites this paper
• Pathways to improving the awareness, diagnosis and management of lipodystrophy in Brazil: an expert panel discussion

  2025cites this paper
• Hereditary lipodystrophies: how not to miss the diagnosis?

  2025cites this paper
• Lipodystrophy Syndromes: One Name but Many Diseases Highlighting the Importance of Adipose Tissue in Metabolism

  2025cites this paper
• The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions

  2025cites this paper
• Severe Insulin Resistance Syndromes: Clinical Spectrum and Management

  2025cites this paper
• The Role of the AGPAT2 Gene in Adipose Tissue Biology and Congenital Generalized Lipodystrophy Pathophysiology

  2025influential citation
• Lipodystrophy and severe insulin resistance syndrome: epidemiological data from a French national rare diseases registry.

  2025cites this paper
• Diagnosis and Management of Genetic Lipodystrophy Syndromes and its Implications for Atherosclerosis

  2025influential citation
• Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa

  2024influential citation
• Lipodystrophiesyndrome – klinische Präsentation und Management

  2024influential citation
• What if OA cartilage degradation is driven by the infrapatellar fat pad? Insights from lipodystrophy models.

  2024cites this paper
• Assessment of aortomesenteric distance and mesenteric and retroperitoneal adipose tissue thickness in genetic forms of lipodystrophy

  2024cites this paper
• Clinical presentation and management of childhood lipodystrophic syndromes

  2024cites this paper
• A Rare Case of Berardinelli-Seip Syndrome in a Four Month Old Child

  2024cites this paper
• Echocardiographic Alterations of Cardiac Geometry and Function in Patients with Familial Partial Lipodystrophy

  2024cites this paper
• Alterações Ecocardiográficas da Geometria e da Função Cardíaca em Pacientes com Lipodistrofia Familiar Parcial

  2024cites this paper
• Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?

  2024cites this paper
• Effects of Metreleptin in Patients with Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease.

  2024cites this paper
• Impact of lipodystrophy on health-related quality of life: the QuaLip study

  2024cites this paper
• Clinical features of generalized lipodystrophy in Turkey: A cohort analysis

  2023cites this paper
• Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain

  2023cites this paper
• Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women

  2023cites this paper
• From scarcity to solutions: Therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy

  2023cites this paper
• Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report

  2023cites this paper
• Frequency and characteristics of diabetes in lipodystrophies and insulin receptoropathies compared with type 1 and type 2: results from the multicenter DPV registry

  2023cites this paper
• Approach to the Patient with Lipodystrophy.

  2022cites this paper
• Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review

  2022cites this paper
• Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy

  2022influential citation
• Reduced gut microbiota diversity in patients with congenital generalized lipodystrophy

  2022influential citation
• Suggestive Evidence for an Antidepressant Effect of Metreleptin Treatment in Patients with Lipodystrophy

  2022cites this paper
• Coronary arterial calcification in patients with congenital generalised lipodystrophy: A case series

  2022cites this paper
• Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year

  2022influential citation
• Role of Seipin in Human Diseases and Experimental Animal Models

  2022influential citation
• Berardinelli Seip Syndrome: A rare case report.

  2022cites this paper
• Treatment Options for Lipodystrophy in Children

  2022cites this paper
• FDA regulation of adipose cell use in clinical trials and clinical translation

  2022cites this paper
• Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy

  2021cites this paper
• Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy

  2021cites this paper
• La vie sans tissu adipeux : les lipodystrophies généralisées congénitales ; causes, physiopathologie et prise en charge thérapeutique

  2021cites this paper
• Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients with Partial Lipodystrophy.

  2021cites this paper
• Complications of Lipodystrophy Syndromes.

  2021cites this paper
• [Multiple subcutaneous nodules for 46 days in an infant aged 66 days].

  2020influential citation
• Lipodystrophy: A paradigm for understanding the consequences of "overloading" adipose tissue.

  2020cites this paper
• Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications

  2020cites this paper
• High prevalence of congenital generalized lipodystrophy in Piura, Peru.

  2020cites this paper
• Lipodystrophies

  2020cites this paper
• Diagnostic strategies and clinical management of lipodystrophy

  2020cites this paper
• Congenital Generalized Lipoatrophy (Berardinelli-Seip Syndrome) Type 1: Description of Novel AGPAT2 Homozygous Variants Showing the Highly Heterogeneous Presentation of the Disease

  2020cites this paper
• Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People

  2020cites this paper
• Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction

  2020cites this paper
• Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy.

  2020cites this paper
• Congenital generalized lipodystrophy in Taiwan.

  2019cites this paper
• Lipodystrophies, dyslipidaemias and atherosclerotic vascular disease

  2019cites this paper
• Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4.

  2019cites this paper
• Lipodystrophy - A Rare Condition with Serious Metabolic Abnormalities

  2019cites this paper
• Comorbidities and Survival in Patients with Lipodystrophy: An International Chart Review Study.

  2019cites this paper
• Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.

  2019influential citation
• An overview of lipodystrophy and the role of the complement system.

  2019cites this paper
• The worldwide mutational landscape of Berardinelli-Seip congenital lipodystrophy.

  2019cites this paper
• Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPARγ mutants.

  2019cites this paper
• Visceral fat does not contribute to metabolic disease in lipodystrophy

  2019cites this paper
• Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.

  2019cites this paper
• Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.

  2019cites this paper
• BBA-Molecular and Cell Biology of Lipids

  2019cites this paper
• Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy

  2019cites this paper
• Lipodystrophy syndromes . Recommendations for diagnosis and patientmanagement

  2018cites this paper
• A Single Complex Agpat2 Allele in a Patient With Partial Lipodystrophy

  2018cites this paper
• A subset of patients with acquired partial lipodystrophy developing severe metabolic abnormalities

  2018cites this paper
• Renal complications of lipodystrophy: A closer look at the natural history of kidney disease

  2018cites this paper
• Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy

  2018cites this paper
• Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy

  2018cites this paper
• Female adipose tissue-specific Bscl2 knockout mice develop only moderate metabolic dysfunction when housed at thermoneutrality and fed a high-fat diet

  2018cites this paper
• Exploring Seipin: From Biochemistry to Bioinformatics Predictions

  2018cites this paper
• Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities

  2018cites this paper
• Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease

  2018influential citation
• Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.

  2017cites this paper
• Congenital Generalized Lipodystrophy Type 2 in a Patient From a High-Prevalence Area

  2017cites this paper
• Lipodystrophie-Erkrankungen

  2017cites this paper
• First metreleptin treatment for generalized lipodystrophy in Turkey

  2017cites this paper
• Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges

  2017influential citation
• High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli–Seip syndrome

  2017cites this paper
• Clinical outcome in a series of pediatric patients with congenital generalized lipodystrophies treated with dietary therapy

  2017cites this paper
• Structure and Function of Bone Marrow Adipocytes.

  2017cites this paper
• Genetics of Lipodystrophy.

  2017influential citation
• Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy

  2017cites this paper
• Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy.

  2017cites this paper
• Effects of Metreleptin in Pediatric Patients With Lipodystrophy

  2017influential citation
• Ori Gi Nal Ar Tic Le

  year unknowncites this paper